Windtree Therapeutics, Inc., a biotechnology company, focuses on the development of therapeutics for the treatment of acute cardiovascular diseases. Its lead product candidate is istaroxime, which is in Phase 2b clinical trials for the treatment of acute decompensated heart failure, as well as for t... Windtree Therapeutics, Inc., a biotechnology company, focuses on the development of therapeutics for the treatment of acute cardiovascular diseases. Its lead product candidate is istaroxime, which is in Phase 2b clinical trials for the treatment of acute decompensated heart failure, as well as for the treatment of early cardiogenic shock. The company also develops AEROSURF, an aerosolized KL4 surfactant that is in Phase 2b clinical trials to treat respiratory distress syndrome in premature infants; Surfaxin, a lyophilized KL4 surfactant for the treatment of respiratory disease, disorder, or condition in humans; Rostafuroxin, which is in Phase 2b clinical trials for the treatment of genetically associated hypertension; and oral and intravenous SERCA2a activators, which are in preclinical trials for the treatment of chronic and acute heart failure. In addition, it is developing an aPKCi inhibitor, which is in preclinical trials for the treatment of cutaneous malignancies and solid tumors. Windtree Therapeutics, Inc. has a strategic alliance with Laboratorios del Dr. Esteve, S.A. for the development, marketing, and sale of a portfolio of potential KL4 surfactant products; a license, development, and commercialization agreement with Lee’s Pharmaceutical (HK) Ltd. and Zhaoke Pharmaceutical (Hefei) Co. Ltd.; a license agreement with Philip Morris USA, Inc. and Johnson & Johnson; and a collaboration with Battelle Memorial Institute for the development of its aerosol delivery system. The company was formerly known as Discovery Laboratories, Inc. and changed its name to Windtree Therapeutics, Inc. in April 2016. Windtree Therapeutics, Inc. was founded in 1992 and is headquartered in Warrington, Pennsylvania. 詳細を表示
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.0038 | -21.1111111111 | 0.018 | 0.0189 | 0.014 | 68194 | 0.0146654 | CS |
| 4 | -0.0009 | -5.96026490066 | 0.0151 | 0.02 | 0.0125 | 68171 | 0.01531913 | CS |
| 12 | 0.0025 | 21.3675213675 | 0.0117 | 0.034 | 0.01 | 170636 | 0.01825898 | CS |
| 26 | -0.0132 | -48.1751824818 | 0.0274 | 0.0349 | 0.007135 | 314675 | 0.01591574 | CS |
| 52 | -7.7358 | -99.8167741935 | 7.75 | 7.75 | 0.007135 | 389215 | 0.05874404 | CS |
| 156 | -7.7358 | -99.8167741935 | 7.75 | 7.75 | 0.007135 | 378790 | 0.05874404 | CS |
| 260 | -7.7358 | -99.8167741935 | 7.75 | 7.75 | 0.007135 | 368908 | 0.05874404 | CS |
HappyLibrarian
2分前
bobby1151
3分前
gdl
3分前
bbotcs
4分前
LA4321
4分前
FeMike
4分前
mick
5分前
al507
5分前
Knowledge is King
7分前
WhenLambo
8分前
HN_ooh
8分前
Legend431
8分前
boston745
9分前
HappyLibrarian
10分前
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。